{"name":"Nura Bio","slug":"nura-bio","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE16LXdqNmlLalVmR0taMVVpXzlrRG9rRVJvSDdoQVNyMDk2ODI2dkJVaDY0X0JibGhrWlFKMnkyWGdDelh2OEFxT25NVW1PQXRTbHN5UWxkSmxxTHZfV0VRWUxwbHB3TzkzbWtNYkUtUm1WNm80TjI3ZEpGM0hpdw?oc=5","date":"2025-07-01","type":"pipeline","source":"The Pharma Letter","summary":"Vesper Bio brings in new CEO - The Pharma Letter","headline":"Vesper Bio brings in new CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE96VzJxTGx5clRQZW5rbEtGRHdnc1dZdmJPYTJUTnI1SjZhX1hkMEp4Y292NTJ4ckJTQkxmQWpEUkRZenZWX0VVSnh4WWlIOF9pdlF0aUdlTHNqU25lajhr?oc=5","date":"2025-04-14","type":"pipeline","source":"Nature","summary":"People - Nature","headline":"People","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxONkNsZzBVYzVOUjI5cFdOMFJESUVSbG1FWWRFMUNYVzAtcEtkUk52Xzk1cG94a0E2M0pjNU5kMTlEdlpYSjhiMldmdG1BSzJRRlVMdjA4MGJoR1k4REtZNVpYMDhhdkZNaVpNVXZ3Ylo2ZXZXWEVWY1lQMGctcFBWS0piSllqa0plR3ZMcE9rX01tbF9R?oc=5","date":"2025-02-21","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—NIH leaders join health agency exodus - Fierce Biotech","headline":"Chutes & Ladders—NIH leaders join health agency exodus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQMUpkWUxsVlR0cHZ1MjJSczFld2RlNFZNNmxjandyTFNNdm1xdnkzTG8tQ1ZWRFpGX2V0NGxid1h5WlJXcmdpY1U1Q0J3cVhFY0lMQ0YxcTNMWXB5bkZWSTAtNm9hTXpBSXZRVmdLRXhaVjMwX18zSGd1cXl1VXhBd3ZVMHFBQ1lFcG81eDFCMlF2N3hlNzZ1ZUxLbXJtUGMzdjhWb3B4dUdBamg0M29iSzF1Vkdzdw?oc=5","date":"2025-02-18","type":"pipeline","source":"businesswire.com","summary":"Nura Bio Expands Leadership Team with C-Suite Appointments - businesswire.com","headline":"Nura Bio Expands Leadership Team with C-Suite Appointments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQVUtzSkU0dWlZNTVsM3hvYXFkZEgxWTZyR1NOSmxpcUxlemJCMTJuTlZyN2VVcTlYZkFFa211bmRBZWZTZ3JYM0tmcXJmdXlhc1dUZlgyWkhjTU9IUGkxeHJlbmJIZ2JPcGtnd041bkk1T0YwTnp1THdVS0Fnb2ZEVlpKYlE4UmhG?oc=5","date":"2025-02-18","type":"pipeline","source":"The Pharma Letter","summary":"Duo join Nura Bio’s quest in neurological diseases - The Pharma Letter","headline":"Duo join Nura Bio’s quest in neurological diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxNYVZGb1d4SlV6bHhTQ0RSVURidk9lekxZR0JyZlM1OEFCcmNBcnpaNGZCZzdybERwZFNjb2VSSjJmWXJpdUMwbWMxZW93ZXY0SV8wUDRBSVRaaFRxeFpPNXFCZ3JqQUpwbEtWdFNEY2lPYURISVF2QmV4aG8zdmw0dlpxV0RFT3VnV29fRmdkdDd3WkVrM1VJaU5rb0J3aHdGbkhGeE0yRFM4clBOQWxGT0JaTFcxS3VlVHZzNHU1YjlhQlEtcG1OUjlzdEp1QjU5RlNBeXNlcHZJLVl6SVBONkdkTQ?oc=5","date":"2024-11-13","type":"pipeline","source":"prnewswire.com","summary":"75+ Key Companies Charting New Frontiers in Multiple Sclerosis Therapeutic Space | DelveInsight - prnewswire.com","headline":"75+ Key Companies Charting New Frontiers in Multiple Sclerosis Therapeutic Space | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPbVI3LXdlRnZOX29JNGhETWV0cHBxV0pGTTE3Ymw0QWF0THFCcHVFNm9GVnBRd2pwa1FoLUVRNEpOeERUWUtpYjNqUTN0cVM1MzRvSGF1M0RzZ2tCV081Z3Jtc0NqLVJBaDM5VDg0VnlTUnQ3RzRwVklSNEhkbGptZnFSUFhEQldfV2JKVTYza0RGamM0b054ZWRpT3g?oc=5","date":"2024-09-20","type":"pipeline","source":"Fierce Biotech","summary":"2 Kite vets fly over to Kyverna Therapeutics—Chutes & Ladders - Fierce Biotech","headline":"2 Kite vets fly over to Kyverna Therapeutics—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNTk51R19oQlEzZmdmSXluWEpMbE9RTl9TNDBfQnh4TWVmd0tjbkdzdktsTnB6VHcyal9UX05QRHoyNTJoTUFhWjY5T2hzSkFQSjNEX3VLQlZoWFVRYnQzU1MzZzdrWGtERXp2NFBqWllNMVdWdkt4R1BCR2xsSU5pTHZ5WE5IMm5Wakg5RVpqdDhJV1hD?oc=5","date":"2024-09-18","type":"pipeline","source":"Pharmaceutical Technology","summary":"Nura Bio secures funding to advance neuroprotective therapies - Pharmaceutical Technology","headline":"Nura Bio secures funding to advance neuroprotective therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE1mVmx4UHpIc2kwNDhkVHRyNFNKblZBTUdwYnZaeWlja1UyWnZhaDlQZVoyckVWR2pMUVdJYUJ5QklRQ0R5TDRNQ2pwVEF2X1F6WHc?oc=5","date":"2024-09-18","type":"pipeline","source":"The Pharma Letter","summary":"Nura Bio - The Pharma Letter","headline":"Nura Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOQ0xwN2FCeWxnbmk4cHNXUEU1UkQxYWpET0J0eUpHeXkxUVBWeWhaTXBpMXBKX1V1c1pfZEtPT3hYeG5QZy1HdWhELURTalZBVEs5aHVEN3h5b0NxUmRsZ3JRNlVEYUJjZ2l3MEJKSlo0YWxEWHBmZ3BfMzZ1bFBpUE1YdXE2RXIzaWg4aVM0YTlfaEt2?oc=5","date":"2024-09-17","type":"pipeline","source":"BioPharma Dive","summary":"Nura Bio gets $68M, new CEO to advance ‘neuroprotective’ brain drugs - BioPharma Dive","headline":"Nura Bio gets $68M, new CEO to advance ‘neuroprotective’ brain drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPZ3BSVmx1NlR1Smk1ZkpLX014V29PemRIcFNHbVdSWkVTeV8zUDl3VEF3QzJUN056RGdOaHdCWHhFSTY5OHFrbGVaa3VRSFVrczkwNkxqVU9IR0tfeHBMdVk0UHQ1c1hoUldKUGZ4UlVrZHJDTHBiall0dDI1M0ZLNmhpQkVZSi1zZ2xqQktBeURNQmtjWWNNck9n?oc=5","date":"2024-09-17","type":"pipeline","source":"MedCity News","summary":"Neuro Startup Nura Bio Adds $68M to Spare Axons With Its Brain-Penetrating Drug - MedCity News","headline":"Neuro Startup Nura Bio Adds $68M to Spare Axons With Its Brain-Penetrating Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxNTWxZNEhuTENkVWUyN2JqMTFCbS1YcENOY2k1cWxDanZHdkg1OWxGdFdieU9Kcm50VTF3aUxHV2IxRXZPOXRXeC1TSTA1SWZZbTAwY2lBRXVOdE5IYm93X0plV3pEdXA5X3ZUdUd2dUFlZDJuUTFKRUwtbGJMd2tIT2hmb2pGY3hud3NaN2F3RGNRdVd0bkNjc0JsZktXdlEzR1dwbWR5Q0xVZkZjb081WmJhRFlCUUpvVHR6bnlJcTZEeGxvSV96bDB5RUlDVUd5N1F6Q3BtN1hvT1dkZ3ZNRGl1bUVGd0V4TFRKZFMxUFBXaDI1RWc?oc=5","date":"2020-07-29","type":"pipeline","source":"businesswire.com","summary":"Nura Bio Launches to Discover and Develop Neuroprotective Drugs, Backed by $73 Million Series A Financing - businesswire.com","headline":"Nura Bio Launches to Discover and Develop Neuroprotective Drugs, Backed by $73 Million Series A Financing","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}